November 24th, 2011 by Toni Brayer, M.D. in Research
No Comments »
I live on the West Coast, where it is rare to see a smoker. Because it is not socially accepted, smokers are not out in the open. They lurk behind buildings to take a smoke break at work and I don’t even own an ashtray for friends because none of my friends smoke. But San Francisco isn’t the rest of America. In 2010 there were 45.5 million Americans who smoke, with men smoking more than women. Tobacco remains the single largest preventable cause of death and disease in the United States. Each year approximately 433,000 people die of smoking-related illness.
Here are some more stats on American adult smokers. The highest prevalence is American Indians/Alaska Natives (31.4%) followed by whites (21%). Smoking incidence decreases with increasing education and improved economics. By region, the Midwest has the most smokers in Oklahoma, Arkansas, Mississippi, Louisiana, Kentucky, Ohio and West Virginia (22-27%). That is huge.
California and Utah have the lowest percentage of adult smokers at Read more »
*This blog post was originally published at EverythingHealth*
October 4th, 2011 by GruntDoc in News
2 Comments »
This underestimates the increased cost by a huge factor…
Remember how Obama recently waived new ozone regulations at the EPA because they were too costly? Well, it seems that the Obama administration would rather make people with Asthma cough up money than let them make a surely inconsequential contribution to depleting the ozone layer:
Asthma patients who rely on over-the-counter inhalers will need to switch to prescription-only alternatives as part of the federal government’s latest attempt to protect the Earth’s atmosphere.
…But the switch to a greener inhaler will cost consumers more. Epinephrine inhalers are available via online retailers for Read more »
*This blog post was originally published at GruntDoc*
July 25th, 2011 by ChristopherChangMD in Research, Video
No Comments »
Many people are already aware of nebulizer treatments to help with breathing during asthma attacks and other pulmonary conditions.
What many people may not be aware of is that such nebulizer treatments can also potentially be used for chronic sinus infections. One of the best known companies offering such treatment is Sinus Dynamics.
Using one of several different nebulizers, compounded liquid medications (antibiotics and/or steroids) selected by the physician are nebulized/atomized which the patient then breathes into the nasal passages. The small size of the particles allow medication to theoretically move through the tiniest of sinus openings directly onto the infected tissue. Treatments are quick generally lasting 3 – 5 minutes (depending on medication and device). Here’s a video demonstrating how it is used.
Sinus Dynamics™ specifically is contracted by over 14,000 insurance companies across the nation, which means that most patients are able to receive their treatment for little to no cost out of pocket.
Most ENT doctors are already familiar with this product.
Personally, I prescribe Read more »
*This blog post was originally published at Fauquier ENT Blog*
June 14th, 2011 by ChristopherChangMD in Health Tips
2 Comments »
It is a big bummer to be an asthmatic. Not only is breathing a problem, but even the treatment for asthma can cause problems.
Take for example steroid inhalers like advair, symbicort, fluticasone, etc.
All asthma patients know to rinse their mouth out after inhaler use due to risk of oral thrush, but what about from the back of the mouth down to the vocal cords??? This nether region can’t be gargled very easily. One can swallow water to rinse this area out, but the vocal cord region would still not be addressed (otherwise aspiration would occur).
And that leads to potential vocal problems… like fungal laryngitis (or thrush of the voicebox). Here’s a picture of what that looks like. To compare, normal is shown in the smaller picture.
Note the white patches indicative of fungal growth. This fungal infection can lead to symptoms of a mild (if any) sore throat, but most patients complain of hoarseness as their only symptom. Read more »
*This blog post was originally published at Fauquier ENT Blog*
April 29th, 2011 by Linda Burke-Galloway, M.D. in Health Tips, News
No Comments »
The Federal Drug Administration (FDA) recently issued a new warning about a medication that has been used for years and it has sent shock waves throughout my specialty. Terbutaline is an FDA approved medication that is used for asthmatic patients or patients who have significant narrowing of the airways. However for years it has been used as an “off-label” medication to treat preterm labor but now that’s about to change. An off-label drug means it hasn’t been approved for that specific use by the FDA.
According to the FDA, the injectable form of Terbutaline should only be used for a maximum of 24 to 72 hours because the drugs association with heart problems and death. The FDA goes on to say that the oral version (pills) should not be prescribed to treat preterm labor because it’s ineffective and can cause similar problems. As an obstetrician, I feel utterly betrayed. The medication clearly had side effects that included shortness of breath and a racing heart. As resident physicians we were taught that the benefit outweighed the risks of having a premature baby and the patients should try to adjust to the medication. Read more »
*This blog post was originally published at Dr. Linda Burke-Galloway*